Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial
Kurtz, J.E, Hardy-Bessard, A.-C, Deslandres, M, Lavau-Denes, S, Largillier, R, Roemer-Becuwe, C, Weber, B, Guillemet, C, Paraiso, D, Pujade-Lauraine, E
Published in Gynecologic oncology (01.04.2009)
Published in Gynecologic oncology (01.04.2009)
Get full text
Journal Article
Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE
de la Fouchardière, C., Largillier, R., Goubely, Y., Hardy-Bessard, A.-C., Slama, B., Cretin, J., Orfeuvre, H., Paraiso, D., Bachelot, T., Pujade-Lauraine, E.
Published in Annals of oncology (01.12.2009)
Published in Annals of oncology (01.12.2009)
Get full text
Journal Article
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab
Pierga, J.-Y., Bidard, F.-C., Autret, A., Petit, T., Andre, F., Dalenc, F., Levy, C., Ferrero, J.-M., Romieu, G., Bonneterre, J., Lerebours, F., Bachelot, T., Kerbrat, P., Campone, M., Eymard, J.-C., Mouret-Reynier, M.-A., Gligorov, J., Hardy-Bessard, A.-C., Lortholary, A., Soulie, P., Boher, J.-M., Proudhon, C., Charafe-Jaufret, E., Lemonnier, J., Bertucci, F., Viens, P.
Published in Annals of oncology (01.01.2017)
Published in Annals of oncology (01.01.2017)
Get full text
Journal Article
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group
Camilleri-Broët, S., Hardy-Bessard, A. C., Le Tourneau, A., Paraiso, D., Levrel, O., Leduc, B., Bain, S., Orfeuvre, H., Audouin, J., Pujade-Lauraine, E.
Published in Annals of oncology (01.01.2004)
Published in Annals of oncology (01.01.2004)
Get full text
Journal Article
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group
Ray-Coquard, I, Weber, B, Cretin, J, Haddad-Guichard, Z, Lévy, E, Hardy-Bessard, A C, Gouttebel, M C, Geay, J-F, Aleba, A, Orfeuvre, H, Agostini, C, Provencal, J, Ferrero, J M, Fric, D, Dohollou, N, Paraiso, D, Salvat, J, Pujade-Lauraine, É
Published in British journal of cancer (24.02.2009)
Published in British journal of cancer (24.02.2009)
Get full text
Journal Article
Pregnancies after breast cancer: Is there a real need for fertility preservation? Results from the ARTEMIS cohort of 60 young patients
Martin-Babau, J., Toudic-Emily, F., Boivin, A.-H., Burban-Provost, P., Vie, B., Etienne, P.-L., Lamezec, B., Le Fur, E., Vincent, A., Besson, D., Hardy-Bessard, A.-C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Need for a stratified analysis in stage I malignant ovarian germ cell tumors (MOGCT): Prospective survival analysis of cases collection from the French rare malignant ovarian tumors (TMRO) network & GINECO group
de la Motte Rouge, T., Derquin, F., Floquet, A., Edeline, J., Lotz, J.-P., Alexandre, J., Pautier, P., Ferron, G., Boissier, E., Lefeuvre-Plesse, C., Vegas, H., Patsouris, A., Kalbacher, E., Berton-Rigaud, D., Hardy Bessard, A.-C., Lavoué, V., Ray-Coquard, I.L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial
Penault-Llorca, F., Dalenc, F., Chabaud, S., Cottu, P., Allouache, D., Cameron, D., Grenier, J., Venat Bouvet, L., Jegannathen, A., Campone, M., Debled, M., Hardy-Bessard, A.-C., Giacchetti, S., Barthelemy, P., Kaluzinski, L., Mailliez, A., Mouret-Reynier, M.-A., Legouffe, E., Cayre, A., Martinez, M., Delbaldo, C., Mollon-Grange, D., Macaskill, E.J., Sephton, M., Stefani, L., Belgadi, B., Winter, M., Orfeuvre, H., Lacroix-Triki, M., Bonnefoi, H., Bliss, J., Canon, J.-L., Lemonnier, J., Andre, F., Bachelot, T.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
Combined Oral Topotecan plus Carboplatin in Relapsed or Advanced Cervical Cancer: A GINECO Phase I-II Trial
KURTZ, J. E, FREYER, G, PUJADE-LAURAINE, E, JOLY, F, GLADIEFF, L, KAMINSKI, M. C, FABBRO, M, FLOQUET, A, HARDY-BESSARD, A. C, RABAN, N, RAY-COQUARD, I
Published in Anticancer research (01.03.2012)
Get full text
Published in Anticancer research (01.03.2012)
Journal Article
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1
Berger, Frédérique, Marce, Margaux, Hardy-Bessard, Anne-Claire, Bachelot, Thomas, Bièche, Ivan, Pradines, Anne, De La Motte Rouge, Thibault, Canon, Jean-Luc, André, Fabrice, Clatot, Florian, Lemonnier, Jérôme, Marques, Sandrine, Bidard, François-Clement, Achille, M, Alleaume, C, Ammarguellat, H, Arsene, O, Bachelot, T, Barthelemy, P, Barthier, S, Bernard-Marty, C, Bonichon-Lamichhane, N, Bonnin, N, Bouaita, R, Boudrant, A, Brunel, V-A, Chakiba, C, Cheneau, C, Clatot, F, Dalenc, F, De Gramont, A, de La Motte Rouge, T, Deiana, L, Del Piano, F, Delbaldo, C, Delecroix, V, Derbel, O, Desclos, H, D'Hondt, V, Dohollou, N, Dubot, C, Escande, A, Ferrero, J-M, Foa, C, Frenel, J-S, Gardner, M, Garnier Tixidre, C, Genet, D, Gisserot, O, Gozy, M, Greilsamer, C, Grenier, J, Guinet, F, Hardy-Bessard, A-C, Jacquin, J-P, Joly, L, Lachaier, E, Ladoire, S, Laurenty, A-P, Le Scodan, R, Leduc, N, Levache, C, Lorchel, F, Lortholary, A, Lucas, B, Marques, N, Marti, A, Melis, A, Mille, D, Mollon, D, Moreau, L, Moullet, I, Mouret-Reynier, M-A, Najem, A, Nguyen, S, Orfeuvre, H, Paitel, J-F, Petit, T, Pistilli, B, Plaza, J, Riedl, C, Sabatier, R, Soulie, P, Spaeth, D, Stefani, L, Teixeira, L, Trouboul, F, Valmar, C, Vegas, H, Venat-Bouvet, L, Zannetti, A, Bidard, FC, Delaloge, S, Bièche, I, Clatot, Florian, Canon, JL, André, F, Arnould, L, Berger, F, Marques, S
Published in BMJ open (03.03.2022)
Published in BMJ open (03.03.2022)
Get full text
Journal Article
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
Derquin, F., Floquet, A., Hardy-Bessard, A.C., Edeline, J., Lotz, J.P., Alexandre, J., Pautier, P., Angeles, M.A., Delanoy, N., Lefeuvre-Plesse, C., Cancel, M., Treilleux, I., Augereau, P., Lavoue, V., Kalbacher, E., Berton Rigaud, D., Selle, F., Nadeau, C., Gantzer, J., Joly, F., Guillemet, C., Pomel, C., Favier, L., Abdeddaim, C., Venat-Bouvet, L., Provansal, M., Fabbro, M., Kaminsky, M.C., Lortholary, A., Lecuru, F., Coquard, I. Ray, de La Motte Rouge, T.
Published in Gynecologic oncology (01.09.2020)
Published in Gynecologic oncology (01.09.2020)
Get full text
Journal Article
PROSELICA: Health-related quality of life (HRQL) and post-hoc analyses for the phase 3 study assessing cabazitaxel 20 (C20) vs 25 (C25) mg/m2 post-docetaxel (D) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
de Bono, J.S., Hardy-Bessard, A.-C., Kim, C.S., Géczi, L., Ford, D., Mourey, L., Carles, J., Parente, P., Font, A., Kacsó, G., Chadjaa, M., Zhang, W., Bernard, J., Eisenberger, M.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Phase II trial evaluating the combination of eribulin (E)+ bevacizumab (BEV) as first line chemotherapy in patients with metastatic Her2-negative breast cancer (MBC): a GINECO group study
Hardy-Bessard, A.-C., Brocard, F., Leheurteur, M., Melis, A., Dauba, J., Lortholary, A., You, B., Guardiola, E., Grenier, J., Martin-Babau, J., Meunier, J., Follana, P., Savoye, A.-M., Mercier-Blas, A., Marti, A., Despax, R., Barbier, N., Gane, N., Ardisson, P., Segura-Djezzar, C.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Non pegylated liposomal doxorubicin (npld, myocettm) + carboplatin (cb) in patients (pts) with ovarian cancer in late relapse (oclr): a phase 2 gineco study
You, B., Joly, F., Ray-Coquard, I.L., El Kouri, C., Mercier-Blas, A., Berton-Rigaud, D., Kalbacher, E., Cojocarasu, O., Fabbro, M., Cretin, J., Zannetti, A., Abadie-Lacourtoisie, S., Mollon, D., Hardy-Bessard, A.-C., Provansal, M., Freyer, G.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
DU BOIS, Andreas, HERRSTEDT, Jorn, KURZEDER, Christian, JELIC, Svetislav, PUJADE-LAURAINE, Eric, BURGES, Alexander, PFISTERER, Jacobus, GROPP, Martina, STAEHLE, Anne, WIMBERGER, Pauline, JACKISCH, Christian, SEHOULI, Jalid, HARDY-BESSARD, Anne-Claire, MÜLLER, Hans-Helge, HARTER, Philipp, KRISTENSEN, Gunnar, JOLY, Florence, HUOBER, Jens, AVALL-LUNDQVIST, Elisabeth, WEBER, Béatrice
Published in Journal of clinical oncology (20.09.2010)
Published in Journal of clinical oncology (20.09.2010)
Get full text
Journal Article
Paclitaxel‐carboplatin‐gemcitabine (TCG) as first‐line treatment of ovarian cancer: a prospective multicenter phase II study (AGO‐OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO‐OVAR 9, GINECO‐TCG, NSGO‐OC‐0102) comparing TCG with standard TC
BOIS, A., SEHOULI, J., LUND, B., JOLY, F., HUOBER, J., JENSEN, T.S., LEVY, E., HEILMANN, V., BOMAN, K., HARDY‐BESSARD, A.C., BURGES, A., MÄENPÄÄ, J., PUJADE‐LAURAINE, E., PFISTERER, J., GROPP, M., STAEHLE, A., WIMBERGER, P., JACKISCH, C., SCHMALFELDT, B., BELAU, A., LOIBL, S., WOLLSCHLAEGER, K., CANZLER, U., ROCHON, J.
Published in International journal of gynecological cancer (01.11.2005)
Published in International journal of gynecological cancer (01.11.2005)
Get full text
Journal Article
Étude de phase IV de pharmacovigilance portant sur la toxicité cardiaque du trastuzumab en néoadjuvant et adjuvant dans le cancer du sein. Analyse conduite par l’Observatoire des Médicaments et des Innovations Thérapeutiques de Bretagne et des Pays de la Loire (OMIT B PL)
Grudé, F., Campone, M., Lortholary, A., Delva, R., Soulie, P., Kerbrat, P., Ganem, G., Bourgeois, H., Van Hulst, S., Vuillemin, E., Hardy-Bessard, A.-C., Goudier, M.-J., Simon, H., Lucas, B., Priou, F., Riché, C., Gamelin, E.
Published in Oncologie (Paris, France) (01.06.2010)
Published in Oncologie (Paris, France) (01.06.2010)
Get full text
Journal Article
6-day continuous infusion of high-dose ifosfamide with bone marrow growth factors in advanced refractory malignancies
BRAIN, E. C. G, MITA, A, MISSET, J.-L, SOULIE, P, ERRIHANI, H, HARDY BESSARD, A.-C, CHAOUCHE, M, ALEXANDRE, J, DELORD, J.-P, CVITKOVIC, E, JASMIN, C
Published in Journal of cancer research and clinical oncology (01.04.1997)
Published in Journal of cancer research and clinical oncology (01.04.1997)
Get full text
Journal Article
LBA12 eMouvoir: Randomised phase III trial evaluating the impact of a personalized and remote physical activity (PA) for breast cancer survivors (BCS). Results on the quality of life (QoL)
Vanlemmens, L., Lefeuvre-Plesse, C., Thery, J., Bogart, E., Aymes, E., Brochard, M-A., Le Gall, F., Belmimoun, M., Rotsaert, L., Mocaer, H., Prevost, J.B., Chocteau, D., Rhliouch, H., Lauridant Philippin, G., Mulliez, T., Najem, A., Hardy-Bessard, A-C., Lartigau, E., Anota, A., Le Deley, M-C.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
712MO Final overall survival (OS) from the phase III ATALANTE/ENGOT-ov29 trial evaluating atezolizumab (Atz) versus placebo with standard chemotherapy (Cx) plus bevacizumab (bev) in ovarian cancer (OC) patients (pts) with platinum-sensitive relapse (PSR)
Kurtz, J.E., Pujade-Lauraine, E., Oaknin, A., Belin, L., Grimm, C., Kocian, R., Denys, H., Rosengarten, O.S., Follana, P., Sehouli, J., Martinez-Garcia, J., Alexandre, J., Hardy-Bessard, A-C., Frenel, J-S., Sabatier, R., Gladieff, L., De La Motte Rouge, T., Lamichhane, N. Bonichon, Kalbacher, E., Heitz, F.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article